Sentinel lymph node biopsy in breast cancer: Unfiltered radioisotope is superior to filtered

Journal of the American College of Surgeons

Volumn 188, Issue 4, 1999, Pages 377-381

  Linehan, David C ^a   Hill, Arnold D K ^a   Tran, Kathy N ^a   Yeung, Henry ^a   Yeh, Samuel D J ^a   Borgen, Patrick I ^a   Cody, Hiram S III ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYE; ISOSULFAN BLUE; RADIOISOTOPE; TECHNETIUM SULFUR COLLOID TC 99M; UNCLASSIFIED DRUG;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER SCINTISCANNING; CANCER STAGING; CONTROLLED STUDY; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SCINTILLATION CAMERA;

EID: 0032939158     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(98)00314-7     Document Type: Article

References (17)

1. Petrek JA, Blackwood MM. Axillary dissection: current practice and technique. Curr Probl Surg 1995;32:259-323.
2. Cody HS. The impact of mammography in 1096 consecutive patients with breast cancer, 1979-1993. Cancer 1995;76: 1579-1584.
3. Cabanas R. An approach for the treatment of penile carcinoma. Cancer 1977;39:456-466.
4. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-399.
5. Alex JC, Krag DN. Gamma-probe guided localization of lymph nodes. Surg Oncol 1993;2:137-143.
6. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-340.
7. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864-1867.
8. Borgstein PJ, Pijpers R, Comans EF, et al. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998;186: 275-283.
9. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
10. Turner RR, Ollila DW, Krasne DL, Giuliano AE. Histologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997;226:271-278.
11. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345-2350.
12. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818-1822.
13. Borgstein PJ, Meijer S, Pijpers R. Intradermal blue dye to identify sentinel lymphnode in breast cancer. Lancet 1997;349: 1668-1669.
14. O'Hea BJ, Hill ADK, El-Shirbiny A, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998;186:423-427.
15. Reintgen D, Albertini J, Berman C, et al. Accurate nodal staging of malignant melanoma. Cancer Control 1995;405-414.
16. Cody HS, Urban JA. Internal mammary node status: a major prognosticator in axillary node-negative breast cancer. Ann Surg Oncol 1995;2:32-37.
17. Krag DN, Ashikaga T, Harlow SP, Weaver DL. Development of sentinel node targeting technique in breast cancer patients. Breast J 1998;4:67-74.